In a later clinical study, CERT1 was a sound marker of paclitaxel resistance in patients with triple-negative breast cancer subjected to combined 5-fluorouracil / doxorubicin / cyclophosphamide therapy in the presence or absence of paclitaxel 68
PMID: 6091217
If youre looking for medication, coaching, habit support, and tools to help you maintain progress over time, Noom offers a more layered approach to weight management
Du Q, Tan Z, Shi F, Tang M, Xie L, Zhao L, et al
Based on this assessment and your genetic profile (if tested), you'll receive a personalized recommendationoften semaglutide injection as a first-line choice due to its proven efficacy and affordability
Even modest weight loss can significantly improve your quality of life